Abstract:Although pediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections have received the lion's share of public health attention recently, it is important to recognize that common respiratory viruses continue to represent a serious source of illness. Parainfluenza viruses are one of the main causes of hospitalization in children younger than 5 years of age because of acute respiratory tract infection, accounting for up to 17% of these hospitalizations (1). Although more widely associated with pediatric populations, parainfluenza viruses are linked with upper and lower respiratory tract infections in all age groups, with illness ranging from the common cold to pneumonia. In the adult population, parainfluenza viruses are most concerning for their role in exacerbations in patients living with chronic diseases, such as asthma, chronic obstructive pulmonary disease, and congestive heart failure (1–3). Like influenza, parainfluenza viruses enter host epithelial cells via sialic acid residues found throughout the respiratory tract (2). Severity of illness with these viruses has been believed to reflect their tropism for different airway regions; mild symptoms are correlated with infection of the upper respiratory tract, whereas more severe symptoms causing croup, bronchiolitis, and pneumonia occur with infection of the lower respiratory tract (3). This becomes especially dangerous when significant alveolar infection or injury occurs, causing edema and ultimately impairing gas exchange.

Alveolar Repair after Viral Injury: A Tale of Two Cell Types